Skip to content

Decision tool topklinische GGZ voor ouderen met een persoonlijkheidsstoornis: Ontwikkeling en validering.

A decision tool to identify elderly patients with personality disorders in need of highly specialized care: development and validation of an age-specific checklist.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20506
Enrollment
90
Registered
2017-09-11
Start date
2016-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality disorder, older adults

Interventions

Phase 1: patricipation in an expertmeeting by selected experts. Phase 2: filling out the checklist by the clinician.

Sponsors

Mondriaan Hospital, Department of Old Age Psychiatry.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Phase 1: Development of the checklist(Delphi-study): - The clinician is a member of the Expertpanel Persoonlijkheid & Ouderen (EPO). - The clinician works in Mental Health Care. - The clinician works in the Netherlands Phase 2: Validation of the checklist: - Clincians fill out the checklist for outpatients referred to (highly) specialized mental health care because of a (suspicion of a) personality disorder.

Exclusion criteria

Exclusion criteria: None, for both phases there are no additional exclusion criteria.

Design outcomes

Primary

MeasureTime frame
Phase 1: The primary outcome of the Delphi-study is an age-specific checklist to identify elderly patients with a personality disorder in need of highly specialized care. Phase 2: The primary outcome of the validation study is a cut-off point for the checklist with optimal specifity and sensitivity.

Secondary

MeasureTime frame
Phase 2: In the second fase the interrater reliability of the checklist will be determined as well.

Contacts

Public ContactL.A.E. Laheij-Rooijakkers
l.laheij-rooijakkers@maastricht.psyq.nl088-5066363

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)